Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders (Q34594454)

3 August 2017

1 reference

title

Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders (English)

1 reference

3 August 2017

Samet Kose

6

0 references

Ziad Nahas

object named as

Ziad Nahas

2

0 references

author name string

Mark S George

1

1 reference

3 August 2017

Jeffrey J Borckardt

3

1 reference

3 August 2017

Berry Anderson

4

1 reference

3 August 2017

Carol Burns

5

1 reference

3 August 2017

E Baron Short

7

1 reference

3 August 2017

1 January 2007

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

3 August 2017

1 reference

3 August 2017

7

1 reference

3 August 2017

1

1 reference

3 August 2017

63-74

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

3 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Effectiveness of electroconvulsive therapy in community settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Positioning of vagal nerve stimulators: technical note

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Transcranial magnetic stimulation: applications in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Deep brain stimulation for treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Inhibition of experimental seizures in canines by repetitive vagal stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Organization of peptidergic and catecholaminergic efferents from the nucleus of the solitary tract to the rat amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

The organization of projections from the cortex, amygdala, and hypothalamus to the nucleus of the solitary tract in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

A review of functional neuroimaging studies of vagus nerve stimulation (VNS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Cerebral blood flow changes during vagus nerve stimulation for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Cerebral activation during vagus nerve stimulation: a functional MR study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Enhanced recognition memory following vagus nerve stimulation in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study. First International Vagus Nerve Stimulation Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Vagus nerve stimulation: a new tool for brain research and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Vagus nerve stimulation is associated with mood improvements in epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

The place of anticonvulsant therapy in bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Seizure suppression by systemic epinephrine is mediated by the vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

21 January 2018

II.—WHAT IS AN EMOTION ?

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Left vagus nerve stimulation suppresses experimentally induced pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Neuroanatomically based approaches to obsessive-compulsive disorder. Neurosurgery and transcranial magnetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

Age effect on far field potentials from the brain stem after transcutaneous vagus nerve stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.1.63

21 January 2018

Identifiers

DOI

10.1586/14737175.7.1.63

1 reference

3 August 2017

1 reference